These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8722416)

  • 21. Cationization of monoclonal antibodies: another step towards the "magic bullet"?
    Vaisitti T; Deaglio S; Malavasi F
    J Biol Regul Homeost Agents; 2005; 19(3-4):105-12. PubMed ID: 16602624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction to this special issue on tumor targeting.
    Goldenberg DM
    Tumour Biol; 2012 Jun; 33(3):571-2. PubMed ID: 22492239
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoclonal antibodies: the good, the bad, and the ugly.
    Myint H
    J Hematother Stem Cell Res; 2003 Feb; 12(1):3-6. PubMed ID: 12662429
    [No Abstract]   [Full Text] [Related]  

  • 24. Whither Radioimmunotherapy: To Be or Not To Be?
    Green DJ; Press OW
    Cancer Res; 2017 May; 77(9):2191-2196. PubMed ID: 28428282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dose radioimmunotherapy in malignant lymphoma.
    Eary JF; Press OW
    Recent Results Cancer Res; 1996; 141():177-82. PubMed ID: 8722427
    [No Abstract]   [Full Text] [Related]  

  • 26. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 27. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal Antibodies.
    Geskin LJ
    Dermatol Clin; 2015 Oct; 33(4):777-86. PubMed ID: 26433849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arming antibodies for cancer therapy.
    Polakis P
    Curr Opin Pharmacol; 2005 Aug; 5(4):382-7. PubMed ID: 15951239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies and immunoconjugates in acute myeloid leukemia.
    Amadori S; Stasi R
    Best Pract Res Clin Haematol; 2006; 19(4):715-36. PubMed ID: 16997179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monoclonal antibodies for diagnosis and therapy in oncological patients].
    Boven E; Haisma HJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2552-8. PubMed ID: 8657317
    [No Abstract]   [Full Text] [Related]  

  • 33. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
    Amadori S; Stasi R
    Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
    Divgi CR; Bander NH; Scott AM; O'Donoghue JA; Sgouros G; Welt S; Finn RD; Morrissey F; Capitelli P; Williams JM; Deland D; Nakhre A; Oosterwijk E; Gulec S; Graham MC; Larson SM; Old LJ
    Clin Cancer Res; 1998 Nov; 4(11):2729-39. PubMed ID: 9829736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma.
    McCune SL; Gockerman JP; Rizzieri DA
    JAMA; 2001 Sep; 286(10):1149-52. PubMed ID: 11559240
    [No Abstract]   [Full Text] [Related]  

  • 36. Abatacept: new drug. Rheumatoid arthritis: after failure of TNF alpha antagonists and rituximab.
    Prescrire Int; 2008 Dec; 17(98):232. PubMed ID: 19422143
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain.
    Miyamoto CT; Brady LW; Rackover MA; Emrich J; Class R; Bender H; Micaily B; Steplewski Z
    Recent Results Cancer Res; 1996; 141():183-92. PubMed ID: 8722428
    [No Abstract]   [Full Text] [Related]  

  • 38. [Radioimmunotherapy with (90)Y-ibritumomab tiuxetan (Zevalin). Spanish Nuclear Medicine Society].
    Bello P; Almoguera MI; Pajares M; Olivas C; Lapeña L; Freire JM;
    Rev Esp Med Nucl; 2010; 29(1):50-2. PubMed ID: 19963305
    [No Abstract]   [Full Text] [Related]  

  • 39. Radioimmunoconjugates for treating cancer: recent advances and current opportunities.
    Bourgeois M; Bailly C; Frindel M; Guerard F; Chérel M; Faivre-Chauvet A; Kraeber-Bodéré F; Bodet-Milin C
    Expert Opin Biol Ther; 2017 Jul; 17(7):813-819. PubMed ID: 28438082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.